South and Central America Embolization Agents Market to Grow at a CAGR of 6.7% to reach US$ 262.40 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South and Central America Embolization Agents Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South and Central America Embolization Agents Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Rising prevalence of vascular diseases.
5.1.3 Advancements in minimally invasive procedures.
5.1.4 Growing demand for targeted cancer therapies.

5.2 Market Opportunities

5.2.1
5.2.2 Development of novel embolization products.
5.2.3 Expansion into emerging markets.
5.2.4 Partnerships with healthcare facilities for training.

5.3 Future Trends

5.3.1
5.3.2 Increased use of biocompatible materials.
5.3.3 Focus on personalized treatment approaches.
5.3.4 Innovations in imaging techniques for procedures.

5.4 Impact of Drivers and Restraints

6. South and Central America Embolization Agents Market Regional Analysis

6.1 South and Central America Embolization Agents Market Overview

6.2 South and Central America Embolization Agents Market Revenue 2019-2028 (US$ Million)

6.3 South and Central America Embolization Agents Market Forecast Analysis

7. South and Central America Embolization Agents Market Analysis – by Product

7.1 Coils

7.1.1 Overview
7.1.2 Coils: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Plugs

7.2.1 Overview
7.2.2 Plugs: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Beads/Particles

7.3.1 Overview
7.3.2 Beads/Particles: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Detachable Balloons

7.4.1 Overview
7.4.2 Detachable Balloons: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Glue

7.5.1 Overview
7.5.2 Glue: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Sponge

7.6.1 Overview
7.6.2 Sponge: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Liquid Embolics

7.7.1 Overview
7.7.2 Liquid Embolics: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.8 Sclerosants

7.8.1 Overview
7.8.2 Sclerosants: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.9 Precipitating Agents

7.9.1 Overview
7.9.2 Precipitating Agents: South and Central America Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

8. South and Central America Embolization Agents Market Analysis – by Application

8.1 Oncology

8.1.1 Overview
8.1.2 Oncology: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Neurology

8.2.1 Overview
8.2.2 Neurology: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Urology

8.3.1 Overview
8.3.2 Urology: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview
8.4.2 Cardiology: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Peripheral Vascular Diseases

8.5.1 Overview
8.5.2 Peripheral Vascular Diseases: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. South and Central America Embolization Agents Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Peripheral Vascular Diseases: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Cardiac Centers

9.2.1 Overview
9.2.2 Peripheral Vascular Diseases: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Ambulatory Surgical Centers

9.3.1 Overview
9.3.2 Peripheral Vascular Diseases: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. South and Central America Embolization Agents Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South and Central America Embolization Agents Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 South and Central America Embolization Agents Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Brazil: South and Central America Embolization Agents Market Breakdown, by Product
10.1.1.1.2 Brazil: South and Central America Embolization Agents Market Breakdown, by Application
10.1.1.1.3 Brazil: South and Central America Embolization Agents Market Breakdown, by End User

10.1.1.2 Argentina: South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Argentina: South and Central America Embolization Agents Market Breakdown, by Product
10.1.1.2.2 Argentina: South and Central America Embolization Agents Market Breakdown, by Application
10.1.1.2.3 Argentina: South and Central America Embolization Agents Market Breakdown, by End User

10.1.1.3 Rest of South and Central America : South and Central America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South and Central America Embolization Agents Market Breakdown, by Product
10.1.1.3.2 Rest of South and Central America : South and Central America Embolization Agents Market Breakdown, by Application
10.1.1.3.3 Rest of South and Central America : South and Central America Embolization Agents Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South and Central America Embolization Agents Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 DePuy Synthes

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 KANEKA CORPORATION

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Medtronic

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Merit Medical Systems Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Stryker Corporation

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Terumo Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights